In clear renal cell carcinoma (cRCC), some studies suggest that the proliferation-inhibitory role of VIP/VIPR1 signaling is related to the activation of EPAC/PI3K pathway 36. This evidence concerns the gene VIP and clear cell renal carcinoma.